For the same period, IHH revenue increased by 27% to RM5.8 billion on higher revenue intensity across all markets as more patients were seen.
IHH Healthcare (SGX:Q0F
) has more than doubled its earnings for the 3QFY2023 ended Sept 30 to RM532.1 million ($152 million)ompared to RM251.8 million for the same period last year, boosted by operational growth from higher patient volumes and revenue intensity from higher acuity treatment.
Accordingly, earnings per share also increased to 6.04 sen for the quarter compared to 2.78 sen in 3QFY2022
